Navigation Links
Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
Date:1/14/2009

ably favourable safety profile of Alpharadin compared to other products used in the treatment of HRPC. This major benefit of Alpharadin makes the ALSYMPCA phase III trial a very attractive option for suitable patients as they can continue to receive best standard care in addition to the study drug."

Results of phase II clinical study BC1-04

The BC1-04 study was a double-blind, randomized, dose-finding, repeat-dose study comparing three different dose levels of Alpharadin given three times with six weeks interval to HRPC patients with skeletal metastases. The drug was given by i.v. injection predominantly on an outpatient basis. The primary study objective was to investigate whether there was a dose-response relationship with respect to the proportion of patients showing a PSA response, and to investigate the six weeks' dosing schedule in order to prepare for possible combination trials with docetaxel.

The primary efficacy objective was met and this showed a dose-dependent effect across the three dose levels; 25 kBq/kg, 50 kBq/kg and 80 kBq/kg, respectively. The secondary, but important, endpoint of bone-specific alkaline phosphatase (b-ALP) also showed a significant dose-dependent effect between the lowest and the two higher dose levels, as well as confirming once more the strong bone-targeting nature of Alpharadin. ALP is a severity marker of metastatic bone disease and of prognostic importance. Again, the benign safety profile of Alpharadin was confirmed. Importantly for a drug in this clinical setting no significant bone marrow toxicity was observed in patients receiving Alpharadin, which suggests that in addition to being a product of choice for patients with bone metastases it may also have an ideal profile to be used in combination with other therapies.

Algeta began enrolling patients for the global phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) study in June 2008. A
'/>"/>

SOURCE Algeta
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
2. MicroPhage Successfully Completes Beta Trial for Rapid MRSA Test
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
5. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
6. Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma
7. Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia
8. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
9. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
10. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
11. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...  El Camino Hospital, a leader in the use ... Leaf Patient Monitoring system to help prevent hospital-acquired pressure ... susceptible to bed sores. The decision was ... the system, which showed dramatic improvement in compliance with ... the one of the most effect ways to prevent ...
(Date:7/30/2014)... PITTSBURGH , July 30, 2014   ... Markets Groups Inc.: OTC Pink: UPZS), a Delaware ... a distribution agreement with Larasan Pharmaceutical Corporation ("Larasan"), a ... products.  According to the agreement, US-based Larasan will ... gourmet 6" frozen pizza through Larasan,s vast distribution ...
(Date:7/30/2014)... SANTA CLARA, Calif. , July 30, 2014 /PRNewswire/ ... innovation economy, released a study today that ... venture-backed biopharma and medical device companies.  According to the ... healthcare saw the biggest potential returns since SVB started ... the year of the IPO.  Built on solid healthcare ...
Breaking Medicine Technology:El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 3Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3
...  IRIDEX Corporation (Nasdaq: IRIX ) announced ... of IRIDEX, MicroPulse laser therapy.  The study examined ... central serous chorioretinopathy (CSC).(1) The study concluded tissue-sparing ... for CSC, also known as CSR, an eye ...
... Texas, Jan. 25, 2012 UNT Health Science Center ... Myron (Mike) Jacobson, Ph.D., as the founding dean of ... search we were very pleased to recruit a renowned ... academic leader in pharmacy education, and a successful entrepreneur ...
Cached Medicine Technology:IRIDEX MicroPulse™ Laser Therapy Enhances Visual Function in Patients with Central Serous Chorioretinopathy (CSC) 2IRIDEX MicroPulse™ Laser Therapy Enhances Visual Function in Patients with Central Serous Chorioretinopathy (CSC) 3UNT System Names Jacobson Founding Dean of College of Pharmacy 2UNT System Names Jacobson Founding Dean of College of Pharmacy 3
(Date:7/31/2014)... 2014 FORT LAUDERDALE, FLORIDA – ... leading US Joint Commission Accredited teleradiology and telemedicine ... technologically advanced consumer storage and sharing platform for ... providing valued members the use of its Cloud-based ... already offered by SecondOpinions.com®. , Wide-spread radiologic ...
(Date:7/31/2014)... Lauderale, FL (PRWEB) July 31, 2014 ... accepting referrals of insurance patients seeking massage therapy in ... company provides an option for Licensed Massage Therapists who ... refer these patients to BWT. Should a patient request ... the referral, BWT can then contract the therapist to ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 What’s ... practice provider? Community Health Center of Snohomish answers ... Pediatricians vs. Family Doctors ”. Many adults can ... available to them. Community Health Center hopes to ... and differences between the two. , To ...
(Date:7/31/2014)... When it comes to aesthetics and wellness, ... As such, Natalie Sharp's Pure Vitality Rx ... new, more focused direction and to provide the latest ... Pure Vitality Rx is Oyster Bay's premier aesthetic, anti-aging ... of services primarily dedicated to women. Services include injectables ...
(Date:7/31/2014)... Some pain relief medications can be as ... Every day, 46 people in the U.S. die from ... people are admitted to an emergency room because of opioid ... the dangers of prescription and over-the-counter painkillers and is calling ... more to make these drugs safer. , The full report, ...
Breaking Medicine News(10 mins):Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 2Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 3Health News:Community Health Center of Snohomish County Reveals the Differences Between Pediatricians and Family Practice Providers 2Health News:Natalie Sharp's Pure Vitality Rx Upgrade - Partnership With Shangri-La Spa and Website Facelift! 2Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 2Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 3
... , FARMINGDALE, N.Y., Sept. 2 Misonix, ... invasive ultrasonic medical device technology, which in Europe is used ... health conditions, today announced the restructuring and expansion of its ... created; one for sales and service of the Sonablate(R) 500 ...
... Fox Chase Cancer Center has received an $8 million ... the National Institutes of Health (NCRR/NIH) to expand their ... will support advanced research into the fundamental biological processes ... new treatments. The funds for the grant were made ...
... the total mortality rate from unintentional injury increased in the ... increases were seen in some subgroups analyzed by age, race, ... Hopkins Bloomberg School of Public Health,s Center for Injury Research ... and 64 years old experienced a 230 percent increase in ...
... - Researchers are developing computer models to comb through ... or insurance claims data to automatically classify them based ... to identify the most important causes of injuries so ... of injuries in society," said Mark Lehto, an associate ...
... Washington Post study, approximately 20% of U.S. soldiers returning ... are a substantial number with post-traumatic stress disorder (PTSD), ... has become unacceptable to Army commanders and the soldiers, ... University, however, doctors will now be able to forecast ...
... ... , ... -- Spend one hour with Delaine Anderson, and it,s clear she does not shrink from life,s ... in different parts of the country before that. She even lived seven years in Greece, where ...
Cached Medicine News:Health News:Misonix Restructures and Expands Sales Organization in Europe 2Health News:Misonix Restructures and Expands Sales Organization in Europe 3Health News:Misonix Restructures and Expands Sales Organization in Europe 4Health News:Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility 2Health News:Deaths from unintentional injuries increase for many groups 2Health News:New computer models aim to classify, help reduce injury accidents 2Health News:Keeping the suicidal soldier alive 2Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 2Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 3Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 4
... single-use instruments on the market., Available in standard ... Surgery. , Dual action tips provide maximum ... points to reduce the chance of alternative burn ... eliminates gapping at connection and the need for ...
Disposable sheath for use with 5mm AEM Laparoscopic Instruments ....
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: